How to choose the initial drug treatment for overactive bladder

MacDiarmid, Scott

doi:10.1007/s11884-008-0007-6

Cited by 2 publications

(2 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Antimuscarinics are the mainstay of pharmacologic therapy for OAB. Choice of antimuscarinic agent is beyond the scope of this discussion and has been addressed previously in this journal [14]. In the United States, antimuscarinics are available in immediate-and sustained-release oral formulations as well as an adhesive patch, and more recently, a topical gel.…”

Section: Initial Management Of Oab In Womenmentioning

confidence: 99%

Algorithms for the management of overactive bladder

Kershen

2009

Curr Urol Rep

View full text Add to dashboard Cite

Overactive bladder (OAB) is a highly prevalent and bothersome condition that hampers quality of life in men and women. Increased awareness of available treatment has led growing numbers of patients to seek medical attention in search of relief. Clinical algorithms for the management of OAB would enable physicians who treat these patients to deliver up-to-date, effective care in an expeditious fashion. An algorithmic approach to OAB should allow most patients to receive therapy without the need for an extended evaluation. Patients who fail initial management or have more complicated clinical scenarios should have treatment directed by specialists who can precisely determine the nature of vesicourethral dysfunction underlying their symptoms. This article presents algorithms for the management of OAB in women, men, and patients with neurologic disease.

show abstract

Section: Initial Management Of Oab In Womenmentioning

confidence: 99%

Algorithms for the management of overactive bladder

Kershen

2009

Curr Urol Rep

View full text Add to dashboard Cite

show abstract

“…Anticholinergic agents are the first line of treatment for NDO but they can cause side effects that avoid their use, both on the central nervous system and on the heart. 4,5 NDO is considered as refractory, and the use of bladder botulinum toxin-type A (BTX-A) injection is currently recommended therapy. 6 Local anesthetic agents have been used for topical analgesia intravesically, with or without an electromotive drug administration in the case of painful procedures, to produce mucosal anesthesia for bladder biopsy.…”

Section: Introductionmentioning

confidence: 99%